Stock Market News
Sanofi and Regeneron present more positive data for Dupixent product
2022.10.11 01:42
Sanofi and Regeneron present more positive data for Dupixent product
Budrigannews.com – Healthcare companies Sanofi (NASDAQ:) and partner Regeneron (NASDAQ:) presented on Tuesday more positive data for their Dupixent product.
The companies said new data showed that Dupixent showed a significant histological remission of eosinophilic esophagitis in children 1 to 11 years old. Eosinophilic esophagitis is a chronic inflammatory disease that damages the esophagus and prevents it from working properly.
